| Challenges to effective cancer control in China, India, and Russia PE Goss, K Strasser-Weippl, BL Lee-Bychkovsky, L Fan, J Li, ... The lancet oncology 15 (5), 489-538, 2014 | 514 | 2014 |
| Пробиотики на основе спорообразующих микроорганизмов рода Bacillus и их использование в ветеринарии ЛФ Бакулина, ИВ Тимофеев, НГ Перминова, АФ Полушкина, ... Биотехнология, 48, 2001 | 247 | 2001 |
| Overexpression of fibroblast growth factor receptors FGFR1 and FGFR2 in renal cell carcinoma I Tsimafeyeu, L Demidov, E Stepanova, N Wynn, H Ta Scandinavian journal of urology and nephrology 45 (3), 190-195, 2011 | 71 | 2011 |
| Management of non–clear cell renal cell carcinoma: Current approaches I Tsimafeyeu Urologic Oncology: Seminars and Original Investigations 35 (1), 5-13, 2017 | 61* | 2017 |
| Distribution of EGFR mutations in 10,607 Russian patients with lung cancer EN Imyanitov, IA Demidova, MG Gordiev, ML Filipenko, TV Kekeyeva, ... Molecular diagnosis & therapy 20, 401-406, 2016 | 55 | 2016 |
| Five-year survival of patients with metastatic renal cell carcinoma in the Russian Federation: results from the RENSUR5 registry I Tsimafeyeu, T Zolotareva, S Varlamov, R Zukov, V Petkau, M Mazhbich, ... Clinical genitourinary cancer 15 (6), e1069-e1072, 2017 | 49 | 2017 |
| Hypercoagulability as a prognostic factor for survival in patients with metastatic renal cell carcinoma IV Tsimafeyeu, LV Demidov, AV Madzhuga, OV Somonova, AL Yelizarova Journal of Experimental & Clinical Cancer Research 28, 1-8, 2009 | 44 | 2009 |
| Современные проблемы биотерапии злокачественных опухолей АЮ Барышников, ЛВ Демидов, ЗГ Кадагидзе, ИН Михайлова, ... Вестник Московского онкологического общества, 6-10, 2008 | 39 | 2008 |
| Stereotactic body radiation therapy in combination with systemic therapy for metastatic renal cell carcinoma: a prospective multicentre study N Dengina, T Mitin, S Gamayunov, S Safina, Y Kreinina, I Tsimafeyeu ESMo open 4 (5), e000535, 2019 | 37 | 2019 |
| A role of the FGF-pathway in the VEGF/VEGFR targeting I Tsimafeyeu, L Demidov, N Wynn Cancer Research 71 (8_Supplement), 5157-5157, 2011 | 36* | 2011 |
| Targeting FGFR2 with alofanib (RPT835) shows potent activity in tumour models I Tsimafeyeu, J Ludes-Meyers, E Stepanova, F Daeyaert, D Khochenkov, ... European Journal of Cancer 61, 20-28, 2016 | 34 | 2016 |
| RUSSCO-RSP comparative study of immunohistochemistry diagnostic assays for PD-L1 expression in urothelial bladder cancer L Zavalishina, I Tsimafeyeu, P Povilaitite, G Raskin, Y Andreeva, A Petrov, ... Virchows Archiv 473, 719-724, 2018 | 31 | 2018 |
| Nivolumab in patients with metastatic renal cell carcinoma and chronic hepatitis C virus infection I Tsimafeyeu, R Gafanov, S Protsenko, A Semenova, A Oganesyan, ... Cancer Immunology, Immunotherapy 69, 983-988, 2020 | 29* | 2020 |
| Agreement between PDL1 immunohistochemistry assays and polymerase chain reaction in non-small cell lung cancer: CLOVER comparison study I Tsimafeyeu, E Imyanitov, L Zavalishina, G Raskin, P Povilaitite, ... Scientific Reports 10 (1), 3928, 2020 | 27 | 2020 |
| Current role of radiotherapy for renal-cell carcinoma N Dengina, I Tsimafeyeu, T Mitin Clinical Genitourinary Cancer 15 (2), 183-187, 2017 | 27 | 2017 |
| Renal cell carcinoma in the Russian Federation in 2008 I Tsimafeyeu, E Aksel Malign Tumours 1, 1-4, 2010 | 27* | 2010 |
| OM-RCA-01, a novel humanized monoclonal antibody targeting fibroblast growth factor receptor 1, in renal cell carcinoma model I Tsimafeyeu, E Zaveleva, E Stepanova, W Low Investigational new drugs 31, 1436-1443, 2013 | 25 | 2013 |
| Phase II, multicenter, uncontrolled trial of single-agent capecitabine in patients with non-clear cell metastatic renal cell carcinoma I Tsimafeyeu, L Demidov, G Kharkevich, N Petenko, V Galchenko, ... American Journal of Clinical Oncology 35 (3), 251-254, 2012 | 25 | 2012 |
| Alofanib, an allosteric FGFR2 inhibitor, has potent effects on ovarian cancer growth in preclinical studies A Tyulyandina, D Harrison, W Yin, E Stepanova, D Kochenkov, ... Investigational new drugs 35, 127-133, 2017 | 24 | 2017 |
| FGFR2 overexpression predicts survival outcome in patients with metastatic papillary renal cell carcinoma I Tsimafeyeu, A Khasanova, E Stepanova, M Gordiev, D Khochenkov, ... Clinical and Translational Oncology 19, 265-268, 2017 | 23* | 2017 |
